Camilla Stenmo

Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recombinant activated factor VII in haemophilia patients. A multi-centre, randomised trial

Gili Kenet, Camilla Stenmo, Allan Blemings et al. · Thrombosis and Haemostasis · 2009 · 32 citations

Medicine, Hematology, Pharmacology +16

Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)

Andreas Tiede, Ute Friedrich, Camilla Stenmo et al. · Journal of Thrombosis and Haemostasis · 2011 · 18 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +8

Pharmacokinetics of recombinant factor <scp>XIII</scp> in young children with congenital <scp>FXIII</scp> deficiency and comparison with older patients

Michael D. Williams, Andrew Will, Camilla Stenmo et al. · Haemophilia · 2013 · 16 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

The pharmacokinetics and pharmacodynamics of single‐dose and multiple‐dose recombinant activated factor VII in patients with haemophilia A or B

Ihosvany Fernández Bello, Camilla Stenmo, Nora Butta et al. · Haemophilia · 2017 · 14 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15